X – MPX Bioceutical (Acquired)
MPX Announces Acquisition of Remaining Interests in Massachusetts Companies TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28,...
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation(“MPX” or the “Company”) (CSE: MPX; OTC:MPXEF) announced that GreenMart NLV, LLC (“GreenMart NLV”), a subsidiary of MPX, has been...
MPX Announces Acquisition of Spartan, a Canadian Veteran Advisory Group Acquisition exemplifies MPX’s commitment to fighting opioid addiction amongst veterans and is expected to drive market share expansion in...
MPX Bioceutical Corporation Reports Financial Results for Its Fiscal First Quarter of 2019 Record Quarterly Revenues increased 224% to $14.5M TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical...
MPX Bioceutical Corporation Reports Financial Results for Its Fiscal Year 2018 Company reports FY 2018 revenues of $21.3 million TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation...
TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC:MPXEF) today announced the Company will issue its fiscal 2018 full-year results release...
TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation(“MPX” or the “Company”) (CSE: MPX; OTC:MPXEF) is pleased to announce the Company, through its indirect wholly-owned subsidiary, S8 Management,...
Company to reschedule conference call with shareholders upon finalization of financial results TORONTO, July 30, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC:...
TORONTO, July 26, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) today announced the Company will issue its fiscal 2018 full-year results release on July...
MPX Enters Into Extraction Agreement With Southern California’s Largest Cannabis Processing Facility, Case Farms Collective Relationship will provide a full scale operation of services to MPX’s proprietary specifications and...
MPX Secures Final Approval to Open First Managed Dispensary in Maryland; Schedules Grand Opening for August 4th Production of MPX-branded cannabis to commence at managed facility as Company’s Maryland...
MPX Responds to Arizona Court of Appeals Decision TORONTO, July 06, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) released the following statement in...
MPX Completes Acquisition of Canadian Licensed Producer TORONTO, June 11, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it...
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to update investors on the recently completed US$40 million convertible...
TORONTO, June 06, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that Robert Petch has joined the board of directors...
MPX Raises US$40 Million Secured Convertible Loan To Fund Capacity Development of MPX Assets and Acquisitions TORONTO, ONTARIO, May 29, 2018 – MPX Bioceutical Corporation (“MPX” or the “Company”)...
MPX Signs a Letter of Intent to Acquire Canadian Licenced Producer Canveda TORONTO, April 17, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to...
TORONTO, April 09, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the official opening of the its newest “Health...
Mpx Enjoys Record Monthly Revenue of Cdn$5.2 Million in Arizona TORONTO, April 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) has reported that its managed...
TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to provide an operational and financial update to...
MPX Signs Definitive Agreement to Expand Its Footprint in Arizona TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that...
MPX Reports Q3 Fiscal 2018 Results Execution of Expansion Strategy TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its...
TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce its inclusion in the newly created Horizons Emerging Marijuana...
Exclusive interview with MPX Bioceutical Corporation’s COO Elizabeth Stavola Elizabeth Stavola joined MPX Bioceutical Corporation (CSE: MPX) (OTC: MPXEF) last year. Formerly the Canadian Bioceutical Corporation, the company focuses...
MPX Enters Into Management and Option Agreement With Dispensary in Baltimore, Maryland TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is...
